95.05
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Boston Scientific Corp Borsa (BSX) Ultime notizie
Boston Scientific earnings missed by $0.29, revenue fell short of estimates - Investing.com
Boston Scientific’s SVP Brown Vance sells shares for $458,904 - Investing.com
Boston Scientific’s SVP Brown Vance sells shares for $458,904 By Investing.com - Investing.com India
Boston Scientific (BSX) Q1 Earnings Preview: Consistent Outperformance Expected - GuruFocus
Boston Scientific Presses Its Advantage in Pulsed Field Ablation - Morningstar
Earnings Preview: Boston Scientific - Benzinga
What To Expect From Boston Scientific’s (BSX) Q1 Earnings - Barchart.com
TD Cowen maintains Boston Scientific stock with $115 target - Investing.com
Bearish Options Trading Surges for Boston Scientific (BSX) | BSX Stock News - GuruFocus
Those who invested in Boston Scientific (NYSE:BSX) five years ago are up 157% - Yahoo Finance
Boston Scientific’s Strong Growth Prospects and Resilience Drive Buy Rating - TipRanks
Is Boston Scientific Corporation (BSX) the Best Low Volatility Stock to Buy Now? - Insider Monkey
Boston Scientific (BSX) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance
Boston Scientific gets analyst upgrade on Farapulse PFA strength - MassDevice
Should You Buy Boston Scientific Stock Ahead Of Q1 Earnings? - Barchart.com
Should You Buy Boston Scientific Stock Ahead of Q1 Earnings? - Yahoo Finance
Infusion Pumps Market to Soar at a CAGR of ~10% by 2032, Owing to the Advancements in Technology and Increased Demand in Healthcare | DelveInsight - GlobeNewswire Inc.
Boston Scientific Corporation (BSX): Among the Innovative Healthcare Stocks to Watch in 2025 - Insider Monkey
Boston Scientific (BSX) Q1 Earnings Preview: What You Should Know Beyond the Headline Estimates - Yahoo Finance
Boston Scientific (NYSE:BSX) Ticks All The Boxes When It Comes To Earnings Growth - Yahoo Finance
Needham Upgrades Boston Scientific (WBAG:BSXC) - Nasdaq
Needham upgrades Boston Scientific on easing competition, growth opportunities - Baystreet.ca
This Boston Scientific Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday - Benzinga
A Glimpse Into The Expert Outlook On Boston Scientific Through 13 Analysts - Benzinga
Needham raises Boston Scientific stock to Buy, target at $113 - Investing.com
Boston Scientific Corporation (BSX): A Bull Case Theory - Yahoo Finance
RBC Capital maintains Outperform on Boston Scientific, $116 target - Investing.com
Smart Pills Market Detailed In New Research Report 2025 | Boston - openPR.com
A Look At The Fair Value Of Boston Scientific Corporation (NYSE:BSX) - Yahoo Finance
Truist Lowers Price Target for Boston Scientific (BSX) Ahead of Q1 Results | BSX Stock News - GuruFocus
Boston Scientific (BSX) Ascends But Remains Behind Market: Some Facts to Note - Yahoo Finance
Boston Scientific Corp. stock rises Friday, still underperforms market - MarketWatch
Boston Scientific price target lowered to $113 from $120 at Truist - TipRanks
Is Boston Scientific Gaining or Losing Market Support? - Benzinga
Boston Scientific (BSX) Is Considered a Good Investment by Brokers: Is That True? - Yahoo Finance
Boston Scientific (BSX) Surges 6.8%: Is This an Indication of Further Gains? - Yahoo
FDA clears path for Boston Sci’s Bolt IVL to challenge J&J’s Shockwave - BioWorld MedTech
Lobbying Update: $20,000 of BOSTON SCIENTIFIC CORPORATION lobbying was just disclosed - Nasdaq
What to Expect From Boston Scientific’s Q1 2025 Earnings Report - Nasdaq
Boston Scientific (NYSE:BSX) Announces Robust Q4 Results With Increased Sales And Net Income - Yahoo Finance
Interventional Neurology Market Deep Research 2025-2032 | - openPR.com
What To Expect From Boston Scientific’s Q1 2025 Earnings Report - Barchart.com
PFA non-inferior, even superior, to cryoablation for paroxysmal AF - BioWorld MedTech
Boston Scientific Insiders Sell US$1.8m Of Stock, Possibly Signalling Caution - Yahoo Finance
Health Rounds: Some early breast cancers may not need surgery after chemo - MarketScreener
Boston Scientific (BSX) Stock Moves -1.55%: What You Should Know - Yahoo Finance
Tariffs on medical devices could raise healthcare costs - The Business Journals
Boston Scientific Sued Over Endoscopic Medical Device Patent - Bloomberg Law News
Boston Scientific (BSX) Faces Pressure from New Tariffs - GuruFocus
Stryker, Boston Scientific down as new tariffs impact medtech industry - Seeking Alpha
Price Over Earnings Overview: Boston Scientific - Benzinga
Here's Why Boston Scientific (BSX) is a Strong Growth Stock - Yahoo Finance
Is Boston Scientific (NYSE:BSX) A Risky Investment? - Yahoo Finance
Boston Scientific’s Farapulse matches Medtronic cryoablation in trial - Yahoo Finance
Boston Scientific CEO Michael Mahoney sells $16.4 million in stock By Investing.com - Investing.com South Africa
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):